Pacira BioSciences, Inc.PCRXNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank21
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P21
Within normal range
vs 5Y Ago
-2.1x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-19.75%
202422.46%
20236.45%
202215.56%
202163.20%
20209.23%
201944.30%
2018174.78%
2017-46.84%
201615.37%